Balyasny Asset Management’s Medtronic MDT Stock Holding History

Balyasny Asset Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$728K	Sell	8,400 -10,900	-56%	-$1.04M	﹤0.01%	2208
2025 Q4	$1.85M	Sell	19,300 -218,800	-92%	-$21.3M	﹤0.01%	1903
2025 Q3	$22.7M	Buy	238,100 +208,200	+696%	+$19.1M	0.03%	662
2025 Q2	$2.61M	Sell	29,900 -39,200	-57%	-$3.32M	﹤0.01%	1594
2025 Q1	$6.21M	Sell	69,100 -9,000	-12%	-$805K	0.01%	1148
2024 Q4	$6.24M	Buy	78,100 +24,300	+45%	+$2.1M	0.01%	1175
2024 Q3	$4.84M	Buy	+53,800	New	+$4.53M	0.01%	1258
2024 Q2	–	Sell	-87,900	Closed	-$7.66M	–	2899
2024 Q1	$7.66M	Buy	87,900 +81,500	+1,273%	+$6.96M	0.01%	1051
2023 Q4	$527K	Buy	+6,400	New	+$488K	﹤0.01%	1936
2021 Q3	–	Sell	-6,200	Closed	-$770K	–	2234
2021 Q2	$770K	Buy	+6,200	New	+$778K	﹤0.01%	1402
2021 Q1	–	Sell	-50,000	Closed	-$5.86M	–	1956
2020 Q4	$5.86M	Sell	50,000 -100,000	-67%	-$11M	0.03%	592
2020 Q3	$15.6M	Buy	+150,000	New	+$15.1M	0.11%	261
2018 Q2	–	Sell	-350,000	Closed	-$28.1M	–	2003
2018 Q1	$28.1M	Buy	350,000 +30,000	+9%	+$2.47M	0.12%	242
2017 Q4	$25.8M	Buy	+320,000	New	+$25.6M	0.08%	327

Other funds holding MDT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Balyasny Asset Management's MDT Position: Q1 2026 in Review

Balyasny Asset Management reduced its Medtronic (MDT) stake by 96% in Q1 2026, selling an estimated $103M and leaving 40,328 shares worth $3.49M. The position accounts for ﹤0.01% of the portfolio, ranked #1528.

Balyasny Asset Management first reported a position in MDT in Q2 2013 and has held it in 39 quarters since. The position peaked at $220M in Q2 2025. 2,230 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

Balyasny Asset Management held 40,328 shares of Medtronic worth $3.49M as of Q1 2026.
Balyasny Asset Management sold 1,077,388 Medtronic shares in Q1 2026, an estimated $103M.
Medtronic made up ﹤0.01% of Balyasny Asset Management's portfolio in Q1 2026, its #1528 holding.
Balyasny Asset Management first reported a position in Medtronic in Q2 2013 and has held it in 39 quarters since.
Balyasny Asset Management's Medtronic position peaked at $220M in Q2 2025.
2,230 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.